A two-year-old boy presented with severe failure to thrive, developmental delay, anemia, hepatosplenomegaly, central cataracts, and dysmorphic features. Quantitative analyses of urinary organic acids revealed massive excretion of mevalonic acid, a metabolic precursor of cholesterol and nonsterol isoprenes: 46,000 to 56,200 mmol per mole of creatinine, as compared with 0.2 to 0.3 mmol per mole in normal children. The mevalonic acid concentration in plasma was also greatly increased at 440 mumol per liter (normal, less than 0.05). The activity of mevalonate kinase, the enzyme that catalyzes the first step in mevalonate metabolism, was severely deficient in the patient's fibroblasts, lymphocytes, and lymphoblasts. In the subsequent pregnancy of the patient's mother, gas chromatography-mass spectrometry demonstrated a marked elevation of mevalonic acid in the mother's urine and a 3000-fold elevation, as compared with control levels in the amniotic fluid, suggesting that the fetus was affected. The diagnosis was confirmed by demonstration of the deficiency of mevalonate kinase in amniocytes and ultimately in liver from the abortus. Intermediate activities of the enzyme in both parents indicated an autosomal recessive mode of inheritance. These observations identify an inherited disorder of cholesterol and nonsterol isoprene biosynthesis in humans.
This article has been cited by other articles:
Haas, D., Hoffmann, G. F.
(2007). Mevalonate Kinase Deficiency and Autoinflammatory Disorders. NEJM
356: 2671-2673
[Full Text]
Neven, B., Valayannopoulos, V., Quartier, P., Blanche, S., Prieur, A.-M., Debre, M., Rolland, M.-O., Rabier, D., Cuisset, L., Cavazzana-Calvo, M., de Lonlay, P., Fischer, A.
(2007). Allogeneic Bone Marrow Transplantation in Mevalonic Aciduria. NEJM
356: 2700-2703
[Abstract][Full Text]
Cenedella, R. J., Jacob, R., Borchman, D., Tang, D., Neely, A. R., Samadi, A., Mason, R. P., Sexton, P.
(2004). Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor. J. Lipid Res.
45: 1232-1241
[Abstract][Full Text]
Luz, J. G., Hassig, C. A., Pickle, C., Godzik, A., Meyer, B. J., Wilson, I. A.
(2003). XOL-1, primary determinant of sexual fate in C. elegans, is a GHMP kinase family member and a structural prototype for a class of developmental regulators. Genes Dev.
17: 977-990
[Abstract][Full Text]
Houten, S. M., Schneiders, M. S., Wanders, R. J. A., Waterham, H. R.
(2003). Regulation of Isoprenoid/Cholesterol Biosynthesis in Cells from Mevalonate Kinase-deficient Patients. J. Biol. Chem.
278: 5736-5743
[Abstract][Full Text]
Prietsch, V., Mayatepek, E., Krastel, H., Haas, D., Zundel, D., Waterham, H. R., Wanders, R. J.A., Gibson, K. M., Hoffmann, G. F.
(2003). Mevalonate Kinase Deficiency: Enlarging the Clinical and Biochemical Spectrum. Pediatrics
111: 258-261
[Abstract][Full Text]
Cenedella, R. J., Kuszak, J. R., Al-Ghoul, K. J., Qin, S., Sexton, P. S.
(2003). Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: Thom rats. J. Lipid Res.
44: 198-211
[Abstract][Full Text]
Drenth, J. P. H., van der Meer, J. W. M.
(2001). Hereditary Periodic Fever. NEJM
345: 1748-1757
[Full Text]
Maddala, R. L., Reddy, V. N., Rao, P. V.
(2001). Lovastatin-Induced Cytoskeletal Reorganization in Lens Epithelial Cells: Role of Rho GTPases. IOVS
42: 2610-2615
[Abstract][Full Text]
Honda, M., Tint, G. S., Honda, A., Nguyen, L. B., Chen, T. S., Shefer, S.
(1998). 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts. J. Lipid Res.
39: 647-657
[Abstract][Full Text]
Clayton, P. T
(1998). Disorders of cholesterol biosynthesis. Arch. Dis. Child.
78: 185-189
[Full Text]
Potter, D., Wojnar, J. M., Narasimhan, C., Miziorko, H. M.
(1997). Identification and Functional Characterization of an Active-site Lysine in Mevalonate Kinase. J. Biol. Chem.
272: 5741-5746
[Abstract][Full Text]
Ozand, P. T., Gascon, G. G.
(1991). Topical Review Article: Organic Acidurias: A Review. Part 1. J Child Neurol
6: 196-219
[Abstract]